NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDTirzepatide Mounjaro®
(Overweight and obesity) 		Central nervous system, Drugs used in the treatment of obesity, 04.05
GREENTirzepatide solution for injection in pre-filled pen Mounjaro®
(Type 2 diabetes) 		Endocrine system, GLP-1 mimetics, 06.01.02.03
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Tirzepatide Tirzepatide Endocrine System, Diabetes Mellitus And Hypoglycaemia, Diabetes Mellitus, Blood Glucose Lowering Drugs Blood Glucose Lowering Drugs, Other
Tirzepatide Tirzepatide Gastro-Intestinal System, Obesity, Blood Glucose Lowering Drugs Blood Glucose Lowering Drugs, Other
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
BLMK ICB: Tirzepatide (Mounjaro®) for Treating Type 2 Diabetes (T2DM) in Adults
NHS England Interim Commissioning Guidance: Implementation of the NICE Technology Appraisal TA1026 and the NICE funding variation for tirzepatide (Mounjaro®) for the management of obesity
NICE TA1026: Tirzepatide for managing overweight and obesity
NICE TA924: Tirzepatide for treating type 2 diabetes